Humana filed a lawsuit Sept. 24 against drugmaker Biogen for allegedly inflating both the number and price of prescriptions for three multiple sclerosis drugs.
Payer
Centene's executive vice president of healthcare enterprises has resigned, the health insurance company said in a Sept. 27 filing with the Securities and Exchange Commission.
Blue Cross Blue Shield of Michigan is refuting claims that it should be the target of a lawsuit accusing it of cutting reimbursement rates for substance use disorder treatment during an opioid epidemic.
A survey of Louisiana mental health providers revealed broad dissatisfaction with state managed care organizations.
Ambetter Health Marketplace Insurance is bringing its coverage to New Jersey as it enters the state for the first time.
Advertisement
Centene subsidiary Sunshine Health named Nathan Landsbaum plan president and CEO, the insurer announced Sept. 27.
Humana and Houston-based Kelsey-Seybold Clinic have signed an agreement to bring the provider's over 500 physicians in-network for Medicare Advantage HMO plan enrollees.
Nearly three months after their last contract expired, Anthem and Mountain View, Calif.-based El Camino Health signed a three-year agreement last week.
A UnitedHealth Group digital tool that enables organizations to gauge predicted outcomes of COVID-19 testing approaches on their populations helped guide a Washington, D.C., school's testing program, according to a new study.
Centene and Humana each filed a lawsuit Sept. 22 alleging pharmaceutical company Merck stifled generic drug competition to inflate prices for Zetia and Vytorin, which treat high cholesterol.